Adipose morphology and metabolic disease

Panna Tandon, Rebecca Wafer, James Minchin

Research output: Contribution to journalReview articlepeer-review

Abstract / Description of output

Adipose morphology is defined as the number and size distribution of adipocytes (fat cells) within adipose tissue. Adipose tissue with fewer, but larger adipocytes is termed as having a ‘hypertrophic’ morphology, whereas adipose with many adipocytes, of a smaller size, is termed a ‘hyperplastic’ morphology. Hypertrophic adipose morphology is positively associated with insulin resistance, diabetes and cardiovascular disease. Contrastingly, hyperplastic morphology is associated with improved metabolic parameters. These phenotypic associations suggest that adipose morphology influences risk for cardiometabolic disease. Intriguingly, monozygotic twin studies have determined that adipose morphology is in part genetically determined. Therefore, identifying the genetic regulation of adipose morphology may help predict, prevent and ameliorate insulin resistance and associated metabolic diseases. Here we review the current literature regarding adipose morphology in relation to; (i) metabolic and medical implications, (ii) methods used to assess adipose morphology, and (iii) transcriptional differences between morphologies.
We further highlight three mechanisms hypothesized to promote adipocyte hypertrophy and thus regulate adipose morphology.
Original languageEnglish
JournalJournal of Experimental Biology
Early online date7 Mar 2018
Publication statusE-pub ahead of print - 7 Mar 2018


Dive into the research topics of 'Adipose morphology and metabolic disease'. Together they form a unique fingerprint.

Cite this